3933 — United Laboratories International Holdings Share Price
0.000.00%
Last trade - 00:00- HK$24.60bn
- HK$21.27bn
- CNY13.76bn
- 37
- 58
- 81
- 64
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 7.43 | ||
| PEG Ratio (f) | 0.72 | ||
| EPS Growth (f) | 11.56% | ||
| Dividend Yield (f) | 1.65% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.64 | ||
| Price to Tang. Book | 1.66 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.71 | ||
| EV to EBITDA | 4.99 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 19.48% | ||
| Return on Equity | 19.61% | ||
| Operating Margin | 24.16% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 8,772.49 | 9,703.44 | 11,334.26 | 13,739.88 | 13,758.94 | 14,984.41 | 14,969.48 | 10.39% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +25.32 | +44.78 | +65.52 | +66.44 | -3.68 | +25.01 | -11.4 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
The United Laboratories International Holdings Limited is an investment holding company principally engaged in the sales of intermediate products, bulk medicine and finished products. The Company operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.
Directors
- Hoi Shan Tsoi CHM (37)
- Wing Hon Leung VCH (53)
- Yu ping Fang VPR (52)
- Su Zhu VPR (50)
- Xian Hong Zou VPR (50)
- Siu Chit Choy EDR (42)
- Zhen Guo Dou OTH (39)
- Bing Yang Liu OTH (65)
- Li Hong Su OTH (46)
- Shou Ting Wu OTH (48)
- Wen Yu Zhang OTH (46)
- Shun Teng Zheng OTH (38)
- Peng Oon Chong NID (66)
- Xiao Nan Fu NID (44)
- Ming Song NID (53)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 1st, 1970
- Public Since
- June 15th, 2007
- No. of Employees
- 17,000
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,817,026,508
- Address
- 6 FuK Wang Street, Yuen Long
- Web
- https://www.tul.com.cn/
- Phone
- +852 null26871033
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for 3933
Dividend For 3933.HK - 0.1200 CNY
Dividend For 3933.HK - 0.2800 CNY
Half Year 2025 United Laboratories International Holdings Ltd Earnings Release
Similar to 3933
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the United Laboratories International Holdings share price?
As of Today at 23:53 UTC, shares in United Laboratories International Holdings are trading at HK$13.82. This share price information is delayed by 15 minutes.
How has the United Laboratories International Holdings share price performed this year?
Shares in United Laboratories International Holdings last closed at HK$13.82 and the price had moved by +43.75% over the past 365 days. In terms of relative price strength the United Laboratories International Holdings share price has outperformed the FTSE Developed Asia Pacific Index by +45.39% over the past year.
What are the analyst and broker recommendations for United Laboratories International Holdings?
The overall consensus recommendation for United Laboratories International Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the United Laboratories International Holdings dividend yield?
The United Laboratories International Holdings dividend yield is 1.28% based on the trailing twelve month period.
Does United Laboratories International Holdings pay a dividend?
Last year, United Laboratories International Holdings paid a total dividend of CNY0.17, and it currently has a trailing dividend yield of 1.28%.Looking ahead, shares in United Laboratories International Holdings are due to go ex-dividend on 2025-07-08 and the next dividend pay date is 2025-08-01.
When does United Laboratories International Holdings next pay dividends?
United Laboratories International Holdings are due to go ex-dividend on 2025-07-08 and the next dividend pay date is 2025-08-01. The historic dividend yield on United Laboratories International Holdings shares is currently 1.28%.
How do I buy United Laboratories International Holdings shares?
To buy shares in United Laboratories International Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of United Laboratories International Holdings?
As of the previous close price of HK$13.82, shares in United Laboratories International Holdings had a market capitalisation of HK$24.60bn.
Where are United Laboratories International Holdings shares listed?
Here are the trading details for United Laboratories International Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 3933
What kind of share is United Laboratories International Holdings?
Based on an overall assessment of its quality, value and momentum United Laboratories International Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a United Laboratories International Holdings share price forecast for 2025?
The analyst consensus target price for shares in United Laboratories International Holdings is HK$16.13. That is 16.74% above the last closing price of HK$13.82.
Analysts covering United Laboratories International Holdings currently have a consensus Earnings Per Share (EPS) forecast of CNY1.81 for the next financial year.
Find out moreWhat is the trend in the United Laboratories International Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like United Laboratories International Holdings. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +30.75%.
As of the last closing price of HK$13.82, shares in United Laboratories International Holdings were trading +25.26% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the United Laboratories International Holdings PE Ratio?
The United Laboratories International Holdings PE ratio based on its reported earnings over the past 12 months is 7.43. The shares last closed at HK$13.82.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of United Laboratories International Holdings?
United Laboratories International Holdings' management team is headed by:
- Hoi Shan Tsoi - CHM
- Wing Hon Leung - VCH
- Yu ping Fang - VPR
- Su Zhu - VPR
- Xian Hong Zou - VPR
- Siu Chit Choy - EDR
- Zhen Guo Dou - OTH
- Bing Yang Liu - OTH
- Li Hong Su - OTH
- Shou Ting Wu - OTH
- Wen Yu Zhang - OTH
- Shun Teng Zheng - OTH
- Peng Oon Chong - NID
- Xiao Nan Fu - NID
- Ming Song - NID